Skip to main content
Gillian Zeldin, MD, Gastroenterology, West Orange, NJ

GillianAnnZeldinMD

Gastroenterology West Orange, NJ

Hepatology & Liver Transplantation

Senior Brand Safety Lead Biosimilars Portfolio Novartis Pharmaceuticals

Dr. Zeldin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zeldin's full profile

Already have an account?

  • Office

    30 Eagle Ridge Way
    West Orange, NJ 07052
    Phone+1 347-944-9846

Summary

  • Dr. Gillian Zeldin is a transplant hepatologist in West Orange, NJ. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 26 years. She specializes in hepatology & liver transplantation medicine and is experienced in hepatology, transplant hepatology, biliary tract disease, amyloidosis, and hematologic oncology.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Gastroenterology, 1994 - 1998
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1991 - 1994
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1991
  • Trenton State College
    Trenton State CollegeBA, Biology, 1982 - 1985

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2005 - 2023
  • PA State Medical License
    PA State Medical License 1998 - 2006

Publications & Presentations

PubMed

Journal Articles

  • What is the best immunosuppression in living donor liver transplantation?  
    Ringe B, Moritz M, Zeldin G, Soriano H., Transplantation Proceedings, 1/1/2005
  • Safety and Efficacy of Living Donor Liver Preservation with HTK Solution  
    Ringe B, Braun F, Moritz M, Zeldin G, Soriano, Meyers W., Transplantation Proceedings, 1/1/2005
  • Effect of donor hepatitis C on liver graft survival  
    Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, Zeldin G, Stewart C, Blumberg E, Abrams J, Markmann JF, Transplant Proc., 1/1/2001
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • What is the Best Immunosuppression in Live Donor Liver Transplantation?
    Ringe B, Moritz M, Zeldin Z, Soriano H, American Society of Transplant Surgeons, Miami Beach, Florida, 1/1/2005
  • The outcome of livers from HCV positive donors.
    Velidedeoglu E, Desai N, Campos L, Olthoff K, Shaked A, Forman L, Zeldin GA, Stewart C, Nunes F, Blumberg E, Abrams J, Lucey M., American Society of Transplantation, Chicago, Illinois, 1/1/2001
  • Outcome of transplantation of marginal liver grafts in high-need patients: evaluation of physician based organ allocation.
    Markmann J, Velidedeoglu E, Olthoff K, Shaked A, Zamir G, Stewart C, Zeldin GA, Nunes F, Schultz C, Burke A, Hibbler J, Kovalovich K, Abrams J, Lucey M, American Society of Transplantation, Chicago, Illinois, 1/1/2000
  • Join now to see all

Lectures

  • HCV/HBV therapeutics and patient management 
    Atlanta, Georgia - 1/9./1998
  • Acute/Fulminant Hepatic Failure 
    Drexel University College of Medicine Philadelphia, PA - 1/21/2004
  • Liver Transplant Candidacy Evaluation 
    Drexel University College of Medicine Philadelphia, PA - 1/21/2004
  • Join now to see all

Other

  • Featured guest, Half hour segment on Hepatitis C 
    Fox Philadelphia Focus
    1/5./2000
  • Featured guest, Segment on hepatitis C 
    CN 8, CNN
    1/14/2003